Literature DB >> 32304418

Respiratory Dialysis-A Novel Low Bicarbonate Dialysate to Provide Extracorporeal CO2 Removal.

Matthew E Cove1, Lien Hong Vu1, Troels Ring2,3, William J Federspiel4, John A Kellum3.   

Abstract

OBJECTIVES: We designed a novel respiratory dialysis system to remove CO2 from blood in the form of bicarbonate. We aimed to determine if our respiratory dialysis system removes CO2 at rates comparable to low-flow extracorporeal CO2 removal devices (blood flow < 500 mL/min) in a large animal model.
DESIGN: Experimental study.
SETTING: Animal research laboratory.
SUBJECTS: Female Yorkshire pigs.
INTERVENTIONS: Five bicarbonate dialysis experiments were performed. Hypercapnia (PCO2 90-100 mm Hg) was established in mechanically ventilated swine by adjusting the tidal volume. Dialysis was then performed with a novel low bicarbonate dialysate.
MEASUREMENTS AND MAIN RESULTS: We measured electrolytes, blood gases, and plasma-free hemoglobin in arterial blood, as well as blood entering and exiting the dialyzer. We used a physical-chemical acid-base model to understand the factors influencing blood pH after bicarbonate removal. During dialysis, we removed 101 (±13) mL/min of CO2 (59 mL/min when normalized to venous PCO2 of 45 mm Hg), corresponding to a 29% reduction in PaCO2 (104.0 ± 8.1 vs 74.2 ± 8.4 mm Hg; p < 0.001). Minute ventilation and body temperature were unchanged during dialysis (1.2 ± 0.4 vs 1.1 ± 0.4 L/min; p = 1.0 and 35.3°C ± 0.9 vs 35.2°C ± 0.6; p = 1.0). Arterial pH increased after bicarbonate removal (7.13 ± 0.04 vs 7.21 ± 0.05; p < 0.001) despite no attempt to realkalinize the blood. Our modeling showed that dialysate electrolyte composition, plasma albumin, and plasma total CO2 accurately predict the measured pH of blood exiting the dialyser. However, the final effluent dose exceeded conventional doses, depleting plasma glucose and electrolytes, such as potassium and phosphate.
CONCLUSIONS: Bicarbonate dialysis results in CO2 removal at rates comparable with existing low-flow extracorporeal CO2 removal in a large animal model, but the final dialysis dose delivered needs to be reduced before the technique can be used for prolonged periods.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32304418     DOI: 10.1097/CCM.0000000000004351

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Evaluation of a New Extracorporeal CO2 Removal Device in an Experimental Setting.

Authors:  Matteo Di Nardo; Filippo Annoni; Fuhong Su; Mirko Belliato; Roberto Lorusso; Lars Mikael Broman; Maximilian Malfertheiner; Jacques Creteur; Fabio Silvio Taccone
Journal:  Membranes (Basel)       Date:  2020-12-23

2.  Acid-base balance in hemodialysis patients in everyday practice.

Authors:  Monika Wieliczko; Jolanta Małyszko
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Rethinking Alveolar Ventilation and CO2 Removal.

Authors:  Matthew E Cove; Michael R Pinsky
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

4.  Hemodynamic and Metabolic Tolerance of Acetate-Free Biofiltration in Mechanically Ventilated Critically Ill Patients: A Real-Life Study.

Authors:  Anna Gouin; Pierre Tailpied; Olivier Marion; Laurence Lavayssiere; Chloé Medrano; Marie-Béatrice Nogier; Bruno Seigneuric; Nassim Kamar; Olivier Cointault; Stanislas Faguer
Journal:  J Clin Med       Date:  2021-12-07       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.